Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anette Sommer, Sandra Berndt, Hans-Georg Lerchen, Sabrina Forveille, Allan Sauvat, Dominik Mumberg, Guido Kroemer & Oliver Kepp. (2022) Antibody–drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties. OncoImmunology 11:1.
Read now
Read now
Articles from other publishers (20)
Olena Zaitseva, Annett Hoffmann, Margaretha Löst, Mohamed A. Anany, Tengyu Zhang, Kirstin Kucka, Armin Wiegering, Christoph Otto & Harald Wajant. (2023) Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity. Frontiers in Immunology 14.
Crossref
Crossref
Zhipeng Cao, Ingrid J. Burvenich, Kening Zhao, Clare Senko, Jason Glab, Renee Fogliaro, Zhanqi Liu, Irvin Jose, Hamsa Puthalakath, Nick J. Hoogenraad, Laura D. Osellame & Andrew M. Scott. (2022) Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy. Cancers 14:22, pages 5533.
Crossref
Crossref
Olena Zaitseva, Annett Hoffmann, Christoph Otto & Harald Wajant. (2022) Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhengxi He, Sai Wang, Jinchun Wu, Yangchun Xie & Bin Li. (2022) Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma. Disease Markers 2022, pages 1-13.
Crossref
Crossref
Jonay Poveda, Sara Vázquez‐Sánchez, Ana B Sanz, Alberto Ortiz, Luis M Ruilope & Gema Ruiz‐Hurtado. (2021)
TWEAK–Fn14
as a common pathway in the heart and the kidneys in cardiorenal syndrome
. The Journal of Pathology.
Crossref
Crossref
Ana Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, Timothy G Whitsett, Jeffrey A Winkles, Walter N Hittlerman & Michael G Rosenblum. (2020) Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B. Journal for ImmunoTherapy of Cancer 8:2, pages e001138.
Crossref
Crossref
Diego Martin-Sanchez, Miguel Fontecha-Barriuso, Maria D. Sanchez-Niño, Maria C. Izquierdo, Alvaro C. Ucero, Alberto Ortiz & Ana B. Sanz. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1790
1800
.
Guanglei Hu, Weihui Zeng & Yumin Xia. (2017) TWEAK/Fn14 signaling in tumors. Tumor Biology 39:6, pages 101042831771462.
Crossref
Crossref
Cheryl L. Armstrong, Rebeca Galisteo, Sharron A.N. Brown & Jeffrey A. Winkles. (2016) TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion. Oncotarget 7:49, pages 81474-81492.
Crossref
Crossref
Didier Meulendijks, Ulrik N. Lassen, Lillian L. Siu, Alwin D.R. Huitema, Vaios Karanikas, Morten Mau-Sorensen, Derek J. Jonker, Aaron R. Hansen, Mary E. Simcox, Kathleen J. Schostack, Dean Bottino, Hua Zhong, Markus Roessler, Suzana M. Vega-Harring, Tiantom Jarutat, David Geho, Karen Wang, Mark DeMario, Glenwood D. Goss & Jan H.M. Schellens. (2016) Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. Clinical Cancer Research 22:4, pages 858-867.
Crossref
Crossref
Diego Martin-Sanchez, Miguel Fontecha-Barriuso, Maria D. Sanchez-Niño, Maria C. Izquierdo, Alvaro C. Ucero, Alberto Ortiz & Ana B. Sanz. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
11
.
Francesc Xavier Avilés-Jurado, Ximena Terra, David Gómez, Joan Carles Flores, Antoni Raventós, Elsa Maymó-Masip, Xavier León, Vicente Serrano-Gonzalvo, Joan Vendrell, Enric Figuerola & Matilde R. Chacón. (2014) Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer. European Archives of Oto-Rhino-Laryngology 272:7, pages 1733-1741.
Crossref
Crossref
Ulrik N. Lassen, Didier Meulendijks, Lilian L. Siu, Vaios Karanikas, Morten Mau-Sorensen, Jan H.M. Schellens, Derek J. Jonker, Aaron R. Hansen, Mary E. Simcox, Kathleen J. Schostack, Dean Bottino, Hua Zhong, Markus Roessler, Suzana M. Vega-Harring, Tiantom Jarutat, David Geho, Ka Wang, Mark DeMario & Glenwood D. Goss. (2015) A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers. Clinical Cancer Research 21:2, pages 258-266.
Crossref
Crossref
Ludmilla de Plater, Anne Vincent-Salomon, Frédérique Berger, André Nicolas, Sophie Vacher, Eléonore Gravier, Aurélie Thuleau, Narjesse Karboul, Marion Richardson, Clément Elbaz, Elisabetta Marangoni, Ivan Bièche, Xavier Paoletti, Sergio Roman-Roman, Patricia A. Culp, Bernard Asselain, Véronique Diéras & Didier Decaudin. (2014) Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts. PLoS ONE 9:11, pages e104227.
Crossref
Crossref
Hong Zhou, Khalid A. Mohamedali, Ana Maria Gonzalez-Angulo, Yu Cao, Mary Migliorini, Lawrence H. Cheung, Janine LoBello, Xiudong Lei, Yuan Qi, Walter N. Hittelman, Jeffrey A. Winkles, Nhan L. Tran & Michael G. Rosenblum. (2014) Development of Human Serine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC. Molecular Cancer Therapeutics 13:11, pages 2688-2705.
Crossref
Crossref
Hong Zhou, Walter N. Hittelman, Hideo Yagita, Lawrence H. Cheung, Stuart S. Martin, Jeffrey A. Winkles & Michael G. Rosenblum. (2013) Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors. Cancer Research 73:14, pages 4439-4450.
Crossref
Crossref
Sharron A. N. Brown, Emily Cheng, Mark S. Williams & Jeffrey A. Winkles. (2013) TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain. PLoS ONE 8:6, pages e65248.
Crossref
Crossref
INGVILD PETTERSEN, NINIB BARYAWNO, FRIDA ABEL, WENCHE HELEN BAKKELUND, SVETLANA N. ZYKOVA, JAN-OLOF WINBERG, UGO MOENS, AGNES RASMUSON, PER KOGNER, JOHN INGE JOHNSEN & BALDUR SVEINBJÖRNSSON. (2013) Expression of TWEAK/Fn14 in neuroblastoma: Implications in tumorigenesis. International Journal of Oncology 42:4, pages 1239-1248.
Crossref
Crossref
Michael Croft, Chris A. Benedict & Carl F. Ware. (2013) Clinical targeting of the TNF and TNFR superfamilies. Nature Reviews Drug Discovery 12:2, pages 147-168.
Crossref
Crossref
Mark S. Chapman, Lan Wu, Aldo Amatucci, Steffan N. Ho & Jennifer S. Michaelson. (2013) TWEAK signals through JAK–STAT to induce tumor cell apoptosis. Cytokine 61:1, pages 210-217.
Crossref
Crossref